Published in Exp Eye Res on November 30, 2012
A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients. J Ovarian Res (2014) 1.12
Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation. J Immunol (2014) 1.03
Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking. Front Chem (2014) 0.89
Different subsets of macrophages in patients with new onset tuberculous pleural effusion. PLoS One (2014) 0.84
Increased malignancy of oral squamous cell carcinomas (oscc) is associated with macrophage polarization in regional lymph nodes - an immunohistochemical study. BMC Cancer (2014) 0.84
Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma. PLoS One (2014) 0.81
Distribution and clinical significance of tumour-associated macrophages in pancreatic ductal adenocarcinoma: a retrospective analysis in China. Curr Oncol (2015) 0.81
Macrophage polarisation changes within the time between diagnostic biopsy and tumour resection in oral squamous cell carcinomas--an immunohistochemical study. Br J Cancer (2015) 0.80
Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases. J Ophthalmol (2015) 0.78
MFHAS1 promotes colorectal cancer progress by regulating polarization of tumor-associated macrophages via STAT6 signaling pathway. Oncotarget (2016) 0.76
Biomodulatory metronomic therapy in stage IV melanoma is well-tolerated and may induce prolonged progression-free survival, a phase I trial. J Eur Acad Dermatol Venereol (2015) 0.76
ZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma Progression. Sci Rep (2017) 0.75
Guanylate-binding protein 5 is a marker of interferon-γ-induced classically activated macrophages. Clin Transl Immunology (2016) 0.75
Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol (2010) 6.85
Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res (2004) 3.83
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer (2011) 3.45
Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes (2009) 3.27
Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS. Br J Cancer (2005) 2.13
Macrophage polarization in the maculae of age-related macular degeneration: a pilot study. Pathol Int (2011) 1.62
Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci (2001) 1.41
The genetics of uveal melanoma: an emerging framework for targeted therapy. Pigment Cell Melanoma Res (2012) 1.39
Detection of M2-macrophages in uveal melanoma and relation with survival. Invest Ophthalmol Vis Sci (2011) 1.37
MAPK kinases as nucleo-cytoplasmic shuttles for PPARgamma. Cell Cycle (2007) 1.37
Pathological and prognostic features of uveal melanomas. Can J Ophthalmol (2004) 1.31
Prognosis in uveal melanoma with extrascleral extension. Arch Ophthalmol (1980) 1.30
Microvessel count predicts survival in uveal melanoma. Cancer Res (1996) 1.27
Lymphocytic infiltration in uveal malignant melanoma. Cancer (1990) 1.18
In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages. J Immunol (2010) 1.15
Macrophages in uveal melanoma and in experimental ocular tumor models: Friends or foes? Prog Retin Eye Res (2010) 1.08
Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma. Invest Ophthalmol Vis Sci (2008) 1.08
Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma. PPAR Res (2009) 1.06
PEDF inhibits IL8 production in prostate cancer cells through PEDF receptor/phospholipase A2 and regulation of NFκB and PPARγ. Cytokine (2011) 1.05
Constitutive overexpression of pigment epithelium-derived factor inhibition of ocular melanoma growth and metastasis. Invest Ophthalmol Vis Sci (2009) 1.05
HLA expression and tumor-infiltrating immune cells in uveal melanoma. Graefes Arch Clin Exp Ophthalmol (1996) 1.01
Pigment epithelium-derived factor induces THP-1 macrophage apoptosis and necrosis by the induction of the peroxisome proliferator-activated receptor gamma. Mol Immunol (2007) 0.98
Hedgehog-mediated regulation of PPARγ controls metabolic patterns in neural precursors and shh-driven medulloblastoma. Acta Neuropathol (2012) 0.93
Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma during malignant melanoma progression. J Cutan Pathol (2008) 0.91
Anti-proliferative effect of peroxisome proliferator-activated receptor gamma agonists on human malignant melanoma cells in vitro. Anticancer Drugs (2006) 0.89
PPARgamma expression in breast cancer: clinical value and correlation with ERbeta. Histopathology (2005) 0.89
Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma. Invest Ophthalmol Vis Sci (2012) 0.87
Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival. Pathol Oncol Res (2012) 0.83
Altered peroxisome-proliferator activated receptors expression in human endometrial cancer. PPAR Res (2012) 0.82
Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases. PPAR Res (2012) 0.81
Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis. Oncoimmunology (2012) 0.80
Idealized PPARγ-Based Therapies: Lessons from Bench and Bedside. PPAR Res (2012) 0.80
Leptin and peroxisome proliferator-activated receptor γ expression in colorectal adenoma. World J Gastroenterol (2012) 0.79
Inadvertent evisceration of eyes containing uveal melanoma. Arch Ophthalmol (2009) 4.25
DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature (2011) 3.90
Clinicopathologic findings from lacrimal sac biopsy specimens obtained during dacryocystorhinostomy. Ophthal Plast Reconstr Surg (2003) 2.92
Spontaneous corneal clearing after Descemet's stripping without endothelial replacement. Ophthalmology (2011) 2.81
Reactive retinal astrocytic tumors (so-called vasoproliferative tumors): histopathologic, immunohistochemical, and genetic studies of four cases. Am J Ophthalmol (2012) 2.12
Interface fluid syndrome in human eye bank corneas after LASIK: causes and pathogenesis. Ophthalmology (2007) 1.89
Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy. Am J Ophthalmol (2003) 1.74
Age-related retinopathy in NRF2-deficient mice. PLoS One (2011) 1.71
Clinicopathologic findings in choroidal melanomas after failed transpupillary thermotherapy. Am J Ophthalmol (2003) 1.69
Congenital fibrovascular pupillary membranes: clinical and histopathologic findings. Ophthalmology (2011) 1.67
Ultrastructural correlation of spectral-domain optical coherence tomographic findings in vitreomacular traction syndrome. Am J Ophthalmol (2008) 1.60
Depth-dependent cohesive tensile strength in human donor corneas: implications for refractive surgery. J Refract Surg (2008) 1.58
Serum vascular endothelial growth factor (VEGF) levels correlate with number and location of micrometastases in a murine model of uveal melanoma. Br J Ophthalmol (2010) 1.53
Recommendations for the reporting of tissues removed as part of the surgical treatment of common malignancies of the eye and its adnexa. Mod Pathol (2003) 1.44
Multiple pilomatrixoma in Turner syndrome. Ophthal Plast Reconstr Surg (2009) 1.39
Cohesive tensile strength of human LASIK wounds with histologic, ultrastructural, and clinical correlations. J Refract Surg (2005) 1.33
Morphometric changes of the choriocapillaris and the choroidal vasculature in eyes with advanced glaucomatous changes. Vision Res (2002) 1.27
Mucinous eccrine adenocarcinoma of the eyelid: report of 6 cases. Can J Ophthalmol (2010) 1.24
Corneal ectasia after excimer laser keratorefractive surgery: histopathology, ultrastructure, and pathophysiology. Ophthalmology (2008) 1.22
Ocular adnexal lymphoid proliferations: clinical, histologic, flow cytometric, and molecular analysis of forty-three cases. Ophthalmology (2003) 1.19
Development of a unique small molecule modulator of CXCR4. PLoS One (2012) 1.18
Histologic, ultrastructural, and immunofluorescent evaluation of human laser-assisted in situ keratomileusis corneal wounds. Arch Ophthalmol (2005) 1.18
Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma. Invest Ophthalmol Vis Sci (2010) 1.18
Biomechanical and wound healing characteristics of corneas after excimer laser keratorefractive surgery: is there a difference between advanced surface ablation and sub-Bowman's keratomileusis? J Refract Surg (2008) 1.17
Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest Ophthalmol Vis Sci (2010) 1.17
Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma. Ophthalmology (2005) 1.16
p120-Catenin is required for mouse vascular development. Circ Res (2010) 1.16
Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma. Am J Ophthalmol (2006) 1.12
Primary intraocular lymphoma: clinical, cytologic, and flow cytometric analysis. Ophthalmology (2004) 1.11
Human eyelid meibomian glands and tarsal muscle are recognized by autoantibodies from patients affected by a new variant of endemic pemphigus foliaceus in El-Bagre, Colombia, South America. J Am Acad Dermatol (2010) 1.10
Ocular oncology research: the advance of patient care and science. Am J Ophthalmol (2002) 1.10
HER2 targeted molecular MR imaging using a de novo designed protein contrast agent. PLoS One (2011) 1.09
Long-term histopathologic findings in human corneal wounds after refractive surgical procedures. Am J Ophthalmol (2005) 1.08
Clinicopathologic correlations in giant cell arteritis: a retrospective study of 107 cases. Ophthalmology (2009) 1.08
Dipyrimidine amines: a novel class of chemokine receptor type 4 antagonists with high specificity. J Med Chem (2010) 1.08
Ocular argyrosis after long-term self-application of eyelash tint. Am J Ophthalmol (2006) 1.07
Subconjunctival nanoparticle carboplatin in the treatment of murine retinoblastoma. Arch Ophthalmol (2009) 1.05
Upregulation of CCR3 by age-related stresses promotes choroidal endothelial cell migration via VEGF-dependent and -independent signaling. Invest Ophthalmol Vis Sci (2011) 1.05
Constitutive overexpression of pigment epithelium-derived factor inhibition of ocular melanoma growth and metastasis. Invest Ophthalmol Vis Sci (2009) 1.05
Neural system antigens are recognized by autoantibodies from patients affected by a new variant of endemic pemphigus foliaceus in Colombia. J Clin Immunol (2011) 1.00
Interferon alpha 2b decreases hepatic micrometastasis in a murine model of ocular melanoma by activation of intrinsic hepatic natural killer cells. Invest Ophthalmol Vis Sci (2004) 0.99
Nocardia veterana endogenous endophthalmitis in a cardiac transplant patient. J Ophthalmic Inflamm Infect (2013) 0.98
Ex vivo confocal microscopy of human LASIK corneas with histologic and ultrastructural correlation. Ophthalmology (2005) 0.98
Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization. Exp Mol Pathol (2011) 0.97
Interface fluid syndrome in laser in situ keratomileusis after complicated trabeculectomy. J Cataract Refract Surg (2006) 0.96
Vitreomacular traction syndrome with extensively myelinated nerve fibers. Arch Ophthalmol (2002) 0.95
Conjunctival granulomas caused by synthetic fibers: report of two cases and review of literature. J AAPOS (2005) 0.94
In-vivo xenograft murine human uveal melanoma model develops hepatic micrometastases. Melanoma Res (2008) 0.94
Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma. Invest Ophthalmol Vis Sci (2008) 0.93
Multiple intratarsal keratinous cysts of the eyelid. Ophthal Plast Reconstr Surg (2012) 0.93
Stem cell marker expression in small cell lung carcinoma and developing lung tissue. Hum Pathol (2008) 0.93
Drug and gene delivery to the back of the eye: from bench to bedside. Invest Ophthalmol Vis Sci (2014) 0.93
Clinicopathologic findings in failed descemet stripping automated endothelial keratoplasty. Arch Ophthalmol (2010) 0.92
Optimal laser power to rupture Bruch's membrane and the retinal vein in the pig. Ophthalmic Surg Lasers Imaging (2003) 0.92
Langerhans cell histiocytosis of the orbit: five clinicopathologic cases and review of the literature. Surv Ophthalmol (2012) 0.92
Diffuse anterior retinoblastoma: A review. Saudi J Ophthalmol (2013) 0.91
Clinicopathologic findings in Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol (2010) 0.91
Proliferating trichilemmal cyst of the eyelid. Am J Ophthalmol (2007) 0.91
Rosai-Dorfman disease simulating nodular scleritis and panuveitis. Arch Ophthalmol (2011) 0.90
Anterior diffuse retinoblastoma: mutational analysis and immunofluorescence staining. Arch Pathol Lab Med (2009) 0.90
Treatment of microsporidia keratitis with topical voriconazole monotherapy. Arch Ophthalmol (2011) 0.90
Potential impact of preoperative magnetic resonance imaging of the breast on patient selection for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys (2011) 0.90
H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 and the demethylase LSD1. Hum Pathol (2009) 0.90
Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma. Histopathology (2013) 0.90
Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases. Breast Cancer Res Treat (2007) 0.89
Subconjunctival herniated orbital fat: A benign adipocytic lesion that may mimic pleomorphic lipoma and atypical lipomatous tumor. Am J Surg Pathol (2007) 0.89
Response and long-term control of bone metastases after peptide receptor radionuclide therapy with (177)Lu-octreotate. J Nucl Med (2011) 0.89
Combined immunologic and anti-angiogenic therapy reduces hepatic micrometastases in a murine ocular melanoma model. Curr Eye Res (2006) 0.89
Interface fungal keratitis after endothelial keratoplasty: a clinicopathological report. Ophthalmic Surg Lasers Imaging (2011) 0.89
Metastatic esophageal adenocarcinoma presenting in the iris. Am J Ophthalmol (2007) 0.89
Histopathologic examination of conjunctival tophi in gouty arthritis. Am J Ophthalmol (2005) 0.88
Epstein-barr infection of the retina: case report and review of the literature. Retin Cases Brief Rep (2011) 0.88
Preoperative characterization of basal cell carcinoma comparing tumour thickness measurement by optical coherence tomography, 20-MHz ultrasound and histopathology. Acta Derm Venereol (2012) 0.88
Excimer laser exacerbation of Avellino corneal dystrophy. J Cataract Refract Surg (2007) 0.88
In vivo high-frequency, contrast-enhanced ultrasonography of uveal melanoma in mice: imaging features and histopathologic correlations. Invest Ophthalmol Vis Sci (2011) 0.88
Histologic and ultrastructural findings in human corneas after successful laser in situ keratomileusis. Arch Ophthalmol (2002) 0.87
Adhesion failures determine the pattern of choroidal neovascularization in the eye: a computer simulation study. PLoS Comput Biol (2012) 0.87
Conjunctival stromal tumor: report of 4 cases. Ophthalmology (2011) 0.87
Histiocytoid variant of eccrine sweat gland carcinoma of the eyelid and orbit: report of five cases. Ophthalmology (2002) 0.86
Phakomatous choristoma of the eyelid. Graefes Arch Clin Exp Ophthalmol (2003) 0.86
Clinical, pathologic, and imaging features and biological markers of uveal melanoma. Methods Mol Biol (2014) 0.85
Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas. Arch Ophthalmol (2002) 0.85
Primitive neuroectodermal tumor/Ewing sarcoma of the retina. Arch Pathol Lab Med (2012) 0.85
Host pigment epithelium-derived factor (PEDF) prevents progression of liver metastasis in a mouse model of uveal melanoma. Clin Exp Metastasis (2013) 0.85
Low dose adjuvant angiostatin decreases hepatic micrometastasis in murine ocular melanoma model. Mol Vis (2004) 0.84
Rabbit model of retinoblastoma. J Biomed Biotechnol (2010) 0.84
Giant corneal keloid: case report and review of the literature. Cornea (2010) 0.84
Retinal metastasis simulating cytomegalovirus retinitis. Ophthalmic Surg Lasers Imaging (2012) 0.83
Histopathological analysis of post-laser-assisted in situ keratomileusis corneal ectasia with intrastromal corneal ring segments. Arch Ophthalmol (2005) 0.83
Elevated intraocular pressure following vitreoretinal surgery. Ophthalmol Clin North Am (2004) 0.83
Corneal perforation with secondary congenital aphakia in Peters anomaly. Cornea (2005) 0.83
Deposits of transforming growth factor-beta-induced protein in granular corneal dystrophy type II after LASIK. Cornea (2008) 0.83
Frequency of unintended vein and peripheral nerve biopsy with temporal artery biopsy. Arch Ophthalmol (2009) 0.83
Detection of lymphovascular invasion in vulvar cancer by D2-40 (podoplanin) as a predictor for inguinal lymph node metastases. Onkologie (2009) 0.82
Antibodies to pilosebaceous units along their neurovascular supply routes in a new variant of endemic pemphigus foliaceus in Colombia, South America. Eur J Dermatol (2011) 0.82
The effect of air tamponade on the ingress of ocular surface pathogens in sutureless transconjunctival microincisional vitrectomy. Retina (2013) 0.82